Abstract
The aims of the study are to demonstrate the effect of probiotic use on the healing of radiation proctitis (RP) and evaluate the efficiency of fecal biomarkers at follow-up of the treatment. Thirty-two male/female rats were randomly separated into four groups of eight rats. The first group (control) was not radiated. RP was created by 17.5 Gy single dose rectal irradiation. The second group (RP) was subjected to RP, but not treated. The third group (RP+ASA) was treated with 5-aminosalicylic acid (5-ASA) 250 mg/kg daily by gastric lavage for 14 days after the irradiation, and the forth group (RP+LGG) was treated with Lactobacillus GG (LGG) 25 × 100 million CFU daily. Feces samples were taken at the 7th and 14th day of the treatment for fecal biomarkers. Rectums of the rats were resected at the 14th day by laparotomy. Samples were evaluated both macroscopically and microscopically. RP was achieved both macroscopically and microscopically. Weight loss of RP group is statistically significant (p < 0.005) than other groups. The healing ratio of RP+ASA and RP+LGG groups was significantly better than the RP group (p < 0.005) both macroscopically and microscopically. But there was no significant difference between ASA and LGG groups. Biochemically, fecal calprotectin was found to be more effective than fecal myeloperoxidase and fecal lactoferrin to show the efficacy of treatment of radiation proctitis. The results of our study demonstrate that probiotic is as effective as 5-aminosalicylic in the treatment of radiation proctitis, and fecal calprotectin is a useful biomarker in determining the response to the treatment.
Similar content being viewed by others
References
No author (1983) Radiation-induced proctosigmoiditis. Lancet 1: 1082–1083
Wong MT, Lim JF, Ho KS, Ooi BS, Tang CL, Eu KW (2010) Radiation proctitis: a decade’s experience. Singapore Med J 51:315–319
Eifel PJ, Levenback C, Wharton JT, Oswald MJ (1995) Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 32:1289–1300
Cunningham IG (1980) The management of radiation proctitis. Aust N Z J Surg 50:172–178
Korkut C, Asoglu O, Aksoy M, Kapran Y, Bilge H, Kiremit-Korkut N, Parlak M (2006) Histopathological comparison of topical therapy modalities for acute radiation proctitis in an experimental rat model. World J Gastroenterol 12:4879–4883
Peppercorn MA (1984) Sulfasalazine: pharmacology, clinical use, toxicity, and related new drug development. Ann Intern Med 101:377–386
Kaur IP, Chopra K, Saini A (2002) Probiotics: potential pharmaceutical applications. Eur J Pharm Sci 15:1–9
Bengmark S (2001) Pre-, pro- and synbiotics. Curr Opin Clin Nutr Metab Care 4:571–579
Ritchie ML, Romanuk TN (2012) A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 7:e34938
Marteau PR (2002) Effect of probiotics on pro-inflammatory cytokines and NF-κB activation in ulcerative colitis. Clin Rev Allergy Immunol 22:255–273
Young RJ, Huffman S (2003) Probiotic use in children. J Pediatr Health Care 17:277–283
Ciorba MA, Riehl TE, Rao MS, Moon C, Ee X, Nava GM, Walker MR, Marinshaw JM, Stappenbeck TS, Stenson WF (2012) Lactobacillus probiotic protects intestinal epithelium from radiation injury in a TLR-2/cyclo-oxygenase-2-dependent manner. Gut 61:829–838
Abraham BP, Kane S (2012) Fecal markers: calprotectin and lactoferrin. Gastroenterol Clin N Am 41:483–495
Larsen A, Hovdenak N, Karlsdottir A, Wentzel-Larsen T, Dahl O, Fagerhol MK (2004) Faecal calprotectin and lactoferrin as markers of acute radiation proctitis: a pilot study of eight stool markers. Scand J Gastroenterol 39:1113–1118
Larsen A, Bjørge B, Klementsen B, Helgeland L, Wentzel-Larsen T, Fagerhol MK, Hovdenak N, Dahl O (2007) Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy. Acta Oncol 46:639–650
Hille A, Schmidt-Giese E, Hermann RM (2008) A prospective study of faecal calprotectin and lactoferrin in the monitoring of acute radiation proctitis in prostate cancer treatment. Scand J Gastroenterol 43:52–58
Wagner M, Peterson CG, Sangfelt P (2008) Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease. World J Gastroenterol 14:5584–5589
Hubmann FH (1982) Proctitis cystica profunda and radiation fibrosis in the rectum of the female Wistar rat after X irradiation: a histopathological study. J Pathol 138:193–204
Hovdenak N, Fajardo LF, Hauer-Jensen M (2000) Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy. Int J Radiat Oncol Biol Phys 48:1111–1117
Takemoto S, Shibamoto Y, Ayakawa S, Nagai A, Hayashi A, Ogino H, Baba F, Yanagi T, Sugie C, Kataoka H, Mimura M (2012) Treatment and prognosis of patients with late rectal bleeding after intensity-modulated radiation therapy for prostate cancer. Radiat Oncol 7:87
Kang S, Chum M, Jin Y (2000) Radiation induced proctitis in rat. J Korean Med Sci 15:682–689
Northway M, Scobey M (1988) Radiation proctitis in the rat; sequential changes and effects of anti-inflammatory agents. Cancer 62:1962–1969
Jahraus CD, Bettenhausen D, Malik U, Sellitti M, St Clair WH (2005) Prevention of acute radiation-induced proctosigmoiditis by balsalazide: a randomized, double-blind, placebo controlled trial in prostate cancer patients. Int J Radiat Oncol Biol Phys 63:1483–1487
Ciorba MA, Stenson WF (2009) Probiotic therapy in radiation induced intestinal injury and repair. Molecular structure and the tight junction. Ann N Y Acad Sci 1165:190–194
Gispert JP, McNicholl AG (2009) Questions and answers on the role of faecal calprotectin as biological marker in inflammatory bowel disease. Dig and Liver Dis 41:56–66
Costa F, Mumolo MG, Ceccarelli L, Bellini M (2005) Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn’s disease. Gut 54:364–368
Lamb CA, Mohiuddin MK, Gicquel J (2009) Fecal calprotectin or lactoferrin can identify postoperative recurrence in Crohn’s disease. Br J Surg 96:663–674
Sipponen T, Karkainen P, Savilathi E (2008) Correlation of fecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings. Aliment Pharmacol Ther 28:1221–1229
Sánchez L, Calvo M, Brock JH (1992) Biological role of lactoferrin. Arch Dis Child 67:657–661
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dandin, Ö., Akin, M.L., Balta, A.Z. et al. The Efficacy of Probiotic (Lactobacillus rhamnosus GG) and 5-ASA (Aminosalicylic Acid) in the Treatment of Experimental Radiation Proctitis in Rats. Indian J Surg 77 (Suppl 2), 563–569 (2015). https://doi.org/10.1007/s12262-013-0923-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-013-0923-3